Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
[]
very "presidential" a one of a kind, innovative trial
exciting results
an eloquent presentation
and a heartfelt tribute
#esmo22 
Postdoctoral GU Oncology Research Fellow @DanaFarber | MD '2021, MSc '2019 @USJLiban